Vimarsana
Biggest News Aggregation in the World

Page 12 - Billy Dunn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Billy Dunn Today - Breaking & Trending Today

FDA Official Who Oversaw Aducanumab Approval Retiring - Vimarsana News

FDA Official Who Oversaw Aducanumab Approval Retiring

An FDA official who oversaw the approval of the controversial Alzheimer's therapy aducanumab is retiring from the agency to 'explore other opportunities.'

FDA's Billy Dunn Resigns from Post Amidst Drug Scandal on Alzheimer's—What Happened? - Vimarsana News

FDA's Billy Dunn Resigns from Post Amidst Drug Scandal on Alzheimer's—What Happened?

The recent controversy on the Alzheimer's drug approvals already had an executive stepping down.

FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern - Vimarsana News

FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern

(Reuters) - The U.S. Food and Drug Administration neurosciences head Billy Dunn will retire from his role effective immediately, the health regulator ...

Source: wtvbam.com
U.S. FDA approves Reata's rare genetic disorder drug - Vimarsana News

U.S. FDA approves Reata's rare genetic disorder drug

By Mariam ESunny and Raghav Mahobe (Reuters) -The U.S. Food and Drug Administration on Tuesday approved Reata Pharmaceuticals Inc's drug for the treat...

Source: whbl.com
Why FDA approval of Friedreich's ataxia drug is a game changer - Vimarsana News

Why FDA approval of Friedreich's ataxia drug is a game changer

Reata Pharmaceuticals is aiming to make the drug omaveloxolone available by the second quarter of 2023

Source: qz.com